Patents Laws in Japan

Sure! Here’s a concise overview of Patent Laws in Japan:

πŸ“š Governing Law

Patent Act of Japan (latest major revision in 2014)

Administered by the Japan Patent Office (JPO)

πŸ›οΈ Regulatory Authority

Japan Patent Office (JPO)
The JPO handles patent applications, examinations, and grants.

πŸ” Patentable Inventions

Any new and useful invention which is industrially applicable.

Includes:

Products

Processes

Machines

Compositions of matter

Improvements thereof

🚫 Exclusions from Patentability

Discoveries, scientific theories, mathematical methods.

Aesthetic creations, purely mental acts, or business methods (unless tied to technical means).

Methods for treatment of humans or animals.

Inventions violating public order or morality.

Software is patentable only if it has a technical effect or solves a technical problem.

πŸ•’ Patent Term

Standard patent protection is 20 years from the filing date.

Extensions available for pharmaceuticals and certain other inventions to compensate for regulatory delays.

πŸ“ Application Procedure

Filing patent application with the JPO.

Request examination within 3 years of filing.

JPO conducts substantive examination on novelty, inventive step, and industrial applicability.

If approved, patent is granted and published.

Annual fees required to maintain the patent.

🌐 International Framework

Japan is a member of:

Patent Cooperation Treaty (PCT) β€” allowing international patent applications.

Paris Convention for the Protection of Industrial Property.

Trilateral Cooperation with USPTO and EPO for examination harmonization.

πŸ’‘ Key Points

Japan is known for a strict examination system, focusing heavily on technical aspects.

Software patents are closely scrutinized β€” must demonstrate technical contribution.

Accelerated examination possible for certain cases, e.g., pharmaceuticals or urgent inventions.

πŸ’° Fees

Application fee

Examination request fee

Grant fee

Annual maintenance fees (increase with patent age)

 

LEAVE A COMMENT

0 comments